Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
AptaBio Therapeutics (293780 KS)
Watchlist
23
Analysis
Health Care
•
South Korea
Aptabio Therapeutics Inc. operates pharmaceutical production businesses. The Company produces anticancer drugs and other pharmaceutical products. Aptabio Therapeutics conducts businesses in Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
AptaBio Therapeutics
•
05 Aug 2026 09:56
Primer: AptaBio Therapeutics (293780 KS) - Aug 2026
AptaBio Therapeutics is a clinical-stage biopharmaceutical company focused on developing 'first-in-class' drugs for intractable diseases,...
αSK Primers
98 Views
Share
bearish
•
Cross Asset Strategy
•
07 Oct 2022 23:26
KOSDAQ 150 Rebalance in December Highlighted by Locals
This article discusses the potential inclusions and exclusions of KOSDAQ 150 rebalance in December 2022 (especially those that are highlighted by...
Douglas Kim
Follow
533 Views
Share
bearish
•
Cross Asset Strategy
•
13 May 2022 07:27
Alpha Generating Trading Strategy of KOSDAQ150 Deletions & Additions in June 2022
An alpha generating trading strategy would be to focus on companies with higher probability of getting deleted in the next round of KOSDAQ...
Douglas Kim
Follow
519 Views
Share
bearish
•
Quantitative Analysis
•
29 Jul 2025 17:55
KRX Short Interest Weekly (Jul 25th): LG Chem, Shinhan Group, Hanwha Ocean, Samsung Electronics, SCD
We analyzed KRX short interest report for the past week and highlighted short interest changes in LG Chem, Shinhan Group, Hanwha Ocean, Samsung...
Ke Yan, CFA, FRM
Follow
447 Views
Share
bearish
•
Quantitative Analysis
•
23 Jul 2025 07:05
KRX Short Interest Weekly (Jul 18th): Kakaopay, Korzinc, SK Hynix, Samsung Sds, Hanwha Aerospace
We analyzed KRX short interest report for the past week and highlighted short interest changes in Kakaopay, Korzinc, SK Hynix, Samsung Sds, Hanwha...
Ke Yan, CFA, FRM
Follow
464 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x